Pearl River Capital, LLC Nevro Corp Transaction History

Pearl River Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$81.07 - $121.29 $428,617 - $641,260	-5,287 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$101.99 - $166.36 $539,221 - $879,545	5,287 New	5,287 $615,000
Q4 2020 Feb 12, 2021	SELL	$138.17 - $184.34 $392,402 - $523,525	-2,840 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$114.09 - $145.51 $50,313 - $64,169	441 Added 18.38%	2,840 $396,000
Q2 2020 Aug 10, 2020	BUY	$89.45 - $129.85 $35,690 - $51,810	399 Added 19.95%	2,399 $287,000
Q4 2019 Feb 12, 2020	BUY	$76.41 - $117.54 $152,820 - $235,080	2,000 New	2,000 $235,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $140M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.